Stocks
NeoGenomics, Inc.NEO
NASDAQHealthcareBiotechnology$7.88-1.25%
Specializing in cancer-focused genetic testing and clinical laboratory services, this company provides oncologists with diagnostic and prognostic information. Its comprehensive test menu and pharma services make it a key player in precision medicine. Investors monitor its growth in oncology testing and partnerships with biopharma firms.
Market Cap: $204.6M52W Range: $4.72 – $13.74
Congressional Interest in NeoGenomics, Inc. (NEO)
5 members of Congress have disclosed 7 trades in NeoGenomics, Inc. (NEO), a Healthcare company. The buy/sell breakdown shows 5 purchases versus 2 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
7
Unique Politicians
5
Buys
5
Sells
2
Who in Congress Is Trading NEO?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-05-07 | Gilbert Cisneros | buy | $1K – $15K |
| 2022-03-30 | Dwight Evans | sell | $1K – $15K |